During the past decade, Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 3 clinical trials were completed, i.e. on average, 15.8% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto"" #1 collaborator was "Associazione Italiana di Immunogenetica e Biologia dei Trapianti (AIBT)" with 1 trials as a collaborator, "CML Advocates Network" with 1 trials as a collaborator, "European Leukemia Net" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator and "National Marrow Donor Program" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto"" are "Chronic Myeloid Leukemia" (8 trials), "Leukemia" (5 trials), "Acute Lymphoblastic Leukemia" (3 trials), "Acute Myeloid Leukemia" (3 trials) and "Chronic Lymphocytic Leukemia" (2 trials). Many other conditions were trialed in "Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto"" in a lesser frequency.

Most popular intervention types in "Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto"" are "Drug" (21 trials), "Other" (7 trials), "Procedure" (3 trials), "Behavioral" (1 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Dasatinib" (2 trials), "Imatinib" (2 trials), "Nilotinib" (2 trials), "Ponatinib" (2 trials) and "all-trans retinoic acid (ATRA)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto"" are 37 trials for "All" genders.

Currently, there are NaN active trials in "Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto"". undefined are not yet recruiting, 3 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto", 1 "Phase 1" clinical trials were conducted, 17 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".